Vaccine Manufacturing | Corning

A Legacy of Scalable Vaccine Production and Development

From PYREX® glass, to single-use plastics, to our stacked vessel platforms for scalability, and closed systems for mitigating contamination risk, Corning has been innovating alongside vaccine manufacturers for decades. Corning products have taken part in vaccine production as far back as the development of the Polio vaccine in 1955.

Today, Corning provides a diverse set of single-use products for all your upstream vaccine development and manufacturing needs: from tried and true roller bottles for preliminary scale-up to space-saving and modular Corning® CellSTACK®, HYPERStack® and CellCube® vessels for ramping up vaccine production for clinical trials.

From initial process vaccine development through GMP manufacturing, our team of field application specialists is here to work alongside you every step of the way—from selecting an initial platform and defining your process in the lab to scaling up to full production. Look to Corning support your vaccine development and production and to help accelerate your journey to discovery.

Workflows

Production Workflows for Adherent and Suspension Cell Lines

Production Workflows for Adherent and Suspension Cell Lines

The diagram below demonstrates examples of commonly used adherent and suspension scale-up and production platforms that can support your vaccine development and production needs. As vaccine scale-up progresses, the vessels increase in space efficiency, reducing the cost and minimizing the labor per titer.